Finance entity
All 1 tracked stories fall under one category: earnings. Of the tracked stories, 1 of 1 also mention BMO Capital Markets, the most common co-covered peer. Their average consequence score of 5 runs below the beat's 5.5 for that window.
Last mentioned: 1h ago
Entity pulse
Figures are computed live from our source-verified story record — see our methodology for how impact and sentiment are derived.
All 1 tracked stories fall under one category: earnings. Of the tracked stories, 1 of 1 also mention BMO Capital Markets, the most common co-covered peer. Their average consequence score of 5 runs below the beat's 5.5 for that window. Source depth averages 2 original sources per story, versus 2.1 across the same-window beat baseline. Christopher Sarchi appears in 1 tracked Finance story from August 16, 2026.
Computed from the 1 stories linked to this entity, with beat comparisons drawn from all 25 Finance stories published in the same date window. Shares are omitted below five stories and comparisons below a twenty-story baseline.
Coverage cohort
Other entities that clear the same relevance threshold in stories also covering Christopher Sarchi. Shared-story counts are live from our verified record — not editorial picks.
Replimune missed consensus EPS by $0.03 but held near its 52-week high at $14.97. Insider sales totaling over $650,000 were tax-related, while analyst targets now range up to $17, creating a gap between the $11.86 average target and the stock price.
Christopher Sarchi is linked from 1 story on this site, each scored at or above our 35% relevance threshold — see how these pages are built.
See something wrong on this page — a misattributed entity, a wrong stat, a broken source link? Report a data issue.
